Jey Cheng

Company: Promega

Job title: Senior Research Scientist

Seminars:

Developing Quantitative Cell-based Bioassays to Enable the Discovery and Development of TCR-based Immunotherapies 12:30 pm

We have developed a platform of bioluminescent cell-based bioassays to enable the discovery and development of TCR-based immunotherapies. TCRαβ-deficient Reporter T Cells are designed for the screening and characterization of antigen-specific therapeutic TCRs without the interference of endogenous TCRs. Specifically, CD4+ or CD8+ TCRαβ-deficient cell lines enable the screening of therapeutic TCRs designed against MHCI-…Read more

day: Day One